Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Signaling Lymphocytic Activation Molecule (SLAMF1), C-Fc

Cat. No.AP3F21

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Canine Signaling Lymphocytic Activation Molecule (SLAMF1), C-Fc is a recombinant protein expressed from Mammalian Expression System. Its predicted molecular weight is 52.2 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Canine
Expression System Mammalian Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 52.2 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

Canine SLAMF1 (CD150) is a critical cell-surface glycoprotein expressed on activated lymphocytes, dendritic cells, and macrophages. It serves as a vital self-ligand receptor that modulates immune cell activation and cytokine production. Notably, SLAMF1 is the primary cellular receptor for the Canine Distemper Virus (CDV), facilitating viral entry and lymphotropism. Additionally, recent genomic studies link SLAMF1 variants to canine atopic dermatitis risk in breeds like French Bulldogs and Boxers, making it a key target for infectious disease and allergy research.

Protein Canine Signaling Lymphocytic Activation Molecule (SLAMF1)
Protein Synonym CD150; SLAM; CDw150; IPO-3; Signaling Lymphocytic Activation Molecule Family Member 1
Gene ID 403642
UniProt ID Q95MM9

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket